BioSpace News Archive

- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the William Blair 40 th Annual Growth Stock Conference, which is being held as a virtual event, on June 9-11, 2020 . Encomp

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that due to public health guidance related to the coronavirus (COVID-19) pandemic and for the safety of participants its Annual Meeting has been changed to a virtual format only. As previously announced, the Annual Meeting will be held on June 10, 2020 at

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to PBGM01 broadly for the treatment of GM1 gangliosidosis. PBGM01 is an AAV-delivery gene therapy currently being developed for the treatment of infantile GM1 gangliosidosis (

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) (“FSD Pharma” or the “Company”) today announced the sale of 5.0 million common shares of Pharmadrug Inc. (CSE:BUZZ) (formerly Aura Health) in a privately negotiated transaction at C$0.08 per share for cash proceeds of C$400,000. Under the terms of the sale, the buyer has the option through June 26, 2020 to purchase

AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.

Companion Medical, the producers of InPen, the only FDA-cleared reusable smart insulin pen system, announced that co-founder and CEO, Sean Saint, has been named as one of the Top 50 Healthcare Technology CEOs of 2020 by The Healthcare Technology Report.

The solution will be used to soften social distancing, restore public confidence in the workplace and care for people in homes.

Activ Surgical, a pioneering digital surgery company focused on improving surgical efficiency, accuracy, patients outcomes and accessibility, today announced the appointment of Subhrangshu (Sub) Datta as Chief Operating Officer (COO)

Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that closed on Monday, May 18, 2020. Nautilus’ total funding n

Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve patients’ lives